• ESMO
The study by Alexey Rumyantsev, supported by the RUSSCO/RakFond grant, was cited at the ESMO Congress. Today, on the first day of the congress, at a joint session of ESMO and MASCC, devoted to the management of side effects of antitumor therapy, one of the lecturers K. Jordan used the results of the study of the new regimen for chemotherapy-induced nausea and vomiting prophylaxis, presented by Alexey Rumyantsev earlier this year.
This is another recognition of the importance of our research for practical medicine and the international medical oncology community.